Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

13 May 2021 07:00

RNS Number : 4583Y
Checkit PLC
13 May 2021
Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF UK MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

13 May 2021

Checkit plc

("Checkit" or the "Group")

Β 

Trading update

Β 

Checkit plc (AIM: CKT) announces an unaudited trading update for the three months to 30 April 2021:

Β 

Revenue for three months to

Β 

Β 

30 Apr

2021

30 Apr

2020 *

% Change

Β 

Checkit Connect:

Recurring

1.4

1.1

+30%

Non-recurring

0.3

0.6

(47) %

Total Checkit Connect

1.7

1.7

+1%

Checkit Connect US (Tutela LLC)**:

Recurring

0.1

0.1

+18%

Non-recurring

0.3

0.2

+32%

Total US

0.4

0.3

+29%

Total Checkit BEMS (Non-recurring)

2.2

1.7

+27%

Checkit Group:

Recurring

1.5

1.2

+29%

Non-recurring

2.8

2.5

+9%

Total Group

4.3

3.7

+15%

* Prior year revenue has been normalised to illustrate sales that would have been included in the Group's financial results had Tutela LLC, which was acquired on 4 February 2021, been fully owned by the Group throughout both periods. Excluding the acquisition of Tutela LLC, prior year Group revenue was Β£3.5m

** Checkit Connect US is introduced as a new reporting unit and is shown in GBP on a constant currency basis at a rate of 1.38 USD/GBP

Β 

Overall Group revenue grew by 15% and recurring revenue by 29% compared to the prior year on a normalised* basis.

Β 

Annual recurring revenue (ARR) saw an increase of Β£0.4m (+7%) in the quarter to close at a run rate of Β£6.1m, predominantly driven by new subscription contracts going live with customers.

Β 

Checkit Connect

Β 

Reported recurring revenue growth continues to reflect the benefits of year-on-year ARR growth realised in the quarter.

Β 

Some of the Group's larger hospitality customers impacted by lockdown measures were given the opportunity to take payment and service deferrals. This negatively affected Q1 reported numbers and is expected to unwind in Q2 as lockdown measures continue to ease.

Β 

The decline in non-recurring revenue compared to Q1 FY21 is primarily driven by timing and the on-going repositioning towards a subscription-based pricing model adopted across the Group during FY21.

Β 

Checkit US (Tutela LLC)

Β 

Checkit US is introduced for FY22 reporting and reflects the performance of the newly created US based business unit incorporating the Q1 acquisition of Tutela LLC.

Β 

US revenue grew by 29% in Q1 (on a constant currency basis**) and includes 18% growth in recurring revenue, which was driven by new subscriptions.

Β 

An initiative to convert customers to recurring subscription contracts is already underway.

Β 

Checkit BEMS

Β 

Checkit BEMS sales grew by 27% compared to the prior year due to a significant project delivered in the quarter and the impact of COVID-19 on prior year results in Q1 FY21.

Β 

Cash

Β 

Cash as at 30 April 2021 was Β£10.9m (31 January 2021: Β£11.5m).

Β 

During the period, the Group acquired Tutela LLC for Β£0.6m. Against this, the closing cash position benefitted from the disproportionate weighting of customer annual payments received in Q1 compared to other periods in the year. An unwinding of this cash benefit is expected during FY22.

Β 

Outlook

The Board remains confident in the outlook for the business.

Β 

As previously announced, during the current financial year, investment in sales, marketing and product will be increased to take advantage of the significant opportunities available for Checkit.

Β 

Forward looking statements

This document contains forward looking statements with respect to the business, strategy and plans of Checkit plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Checkit or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Checkit's actual future results may differ materially from the results expressed or implied in these forward-looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. The forward-looking statements contained in this document are made as of the date hereof, and Checkit undertakes no obligation to update any of its forward-looking statements.

Β 

Β Checkit plc +44 (0) 1223 643313

Β www.checkit.net

Β Keith Daley (Executive Chair)

Β Aylsa Muir (Chief Financial Officer)

Β 

Β N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000

Β Shaun Dobson / George Tzimas (Corporate Finance)

Β Rachel Hayes (Corporate Broking)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBLLLFFELLBBE
Date   Source Headline
8th Apr 20269:54 amRNSForm 8.5 (EPT/RI)
7th Apr 202611:44 amRNSForm 8.3 - Checkit plc
7th Apr 202610:30 amRNSForm 8.5 (EPT/RI)
1st Apr 202610:37 amRNSForm 8.5 (EPT/RI)
1st Apr 20269:38 amRNSForm 8.3 - Checkit PLC
1st Apr 20267:47 amRNSForm 8 (OPD) - Checkit plc
31st Mar 20262:50 pmEQSForm 8.3 - Checkit PLC
31st Mar 202611:29 amRNSForm 8.3 - Checkit plc
31st Mar 202611:12 amRNSHolding(s) in Company
31st Mar 202610:51 amRNSForm 8.5 (EPT/RI)
30th Mar 20261:58 pmRNSForm 8.3 - Checkit plc
30th Mar 202610:14 amRNSForm 8.5 (EPT/RI)
27th Mar 20263:39 pmRNSForm 8.3 Check it
27th Mar 20262:43 pmRNSForm 8.3 - Checkit PLC
27th Mar 202611:44 amRNSForm 8.3 - Checkit plc
27th Mar 202611:36 amEQSForm 8.3 - Checkit PLC
27th Mar 202610:40 amRNSForm 8.5 (EPT/RI)
27th Mar 202610:32 amRNSCheckit Plc - Form 8.3
26th Mar 202610:26 amRNSForm 8.3 - Checkit PLC
26th Mar 20267:45 amRNSDisclosure Table
26th Mar 20267:00 amRNSCommencement of Formal Sale Process
19th Feb 20267:00 amRNSFY26 Trading Update
21st Jan 202611:34 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
30th Oct 20251:00 pmRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
13th Oct 20252:52 pmRNSGrant of options and PDMR dealing
25th Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSInterim Results
19th Jun 20252:36 pmRNSGrant of Options
5th Jun 20253:11 pmRNSResult of AGM
29th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSFinal Results
17th Apr 20257:00 amRNSNotice of Results and Investor Presentation
8th Apr 20257:00 amRNSStrategic update
20th Mar 202512:31 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:21 amRNSForm 8.5 (EPT/RI)
19th Mar 202512:02 pmRNSResult of General Meeting
18th Mar 20259:43 amRNSForm 8.5 (EPT/RI)
18th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
17th Mar 20258:56 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 202511:57 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.